Cargando…
Low Expression of ADCY4 Predicts Worse Survival of Lung Squamous Cell Carcinoma Based on Integrated Analysis and Immunohistochemical Verification
PURPOSE: The molecular mechanism underlying the carcinogenesis and development of lung squamous cell carcinoma (LUSC) has not been sufficiently elucidated. This analysis was performed to find pivotal genes and explore their prognostic roles in LUSC. METHODS: A microarray dataset from GEO (GSE19188)...
Autores principales: | Liu, Zhicong, Ru, Lixin, Ma, Zhenchao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8225293/ https://www.ncbi.nlm.nih.gov/pubmed/34178627 http://dx.doi.org/10.3389/fonc.2021.637733 |
Ejemplares similares
-
A Novel Lipid Prognostic Signature of ADCY2, LIPE, and OLR1 in Head and Neck Squamous Cell Carcinoma
por: Gao, Xiaolei, et al.
Publicado: (2021) -
Identification of a Novel Four-Gene Signature Correlated With the Prognosis of Patients With Hepatocellular Carcinoma: A Comprehensive Analysis
por: Zhu, Weihua, et al.
Publicado: (2021) -
A Case–Control Study of ADCY9 Gene Polymorphisms and the Risk of Hepatocellular Carcinoma in the Chinese Han Population
por: Chao, Xu, et al.
Publicado: (2020) -
Intraoperative low-dose dopamine is associated with worse survival in patients with hepatocellular carcinoma: A propensity score matching analysis
por: Wang, Yan, et al.
Publicado: (2022) -
Identification of Survival-Associated Alternative Splicing Signatures in Lung Squamous Cell Carcinoma
por: Liu, Yang, et al.
Publicado: (2020)